N/A N=94 Intramuscular Ketorolac Versus Oral Ibuprofen for Pain Relief in First Trimester Suction Curettage
Pain
Primary: Immediate Post-procedure Pain Score — 52.3; 56.2 units on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=30 Early Increase in Blood Flow (EIBS) in the Duodenum in Patients With Pancreatic Cancer
Pancreatic Cancer
Primary: Deoxyhemoglobin Concentration (DHb) — .6968475; .3483283; .7021826; .4945491 alpha units — p=0.001
N/A N=66 Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases
Chronic Myeloproliferative Disorders · Leukemia · Lymphoma
Primary: Treatment-related Mortality Within the First 6 Months After Transplantation — 6 participants
Phase 4 N=19 Study of EXPAREL in Patients Undergoing Breast Augmentation
Mammoplasty · Postoperative Pain
Primary: Duration of Analgesia — 0.07; 0.3; 4.28; 4.82 hours
Phase 4 N=201 A Study of Tocilizumab Added to DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to DMARDs.
Rheumatoid Arthritis
Primary: Health Assessment Questionnaire (HAQ) Score — 1.93; 1.49; 1.22; 1.08 units on a scale
Phase 3 N=329 Safety and Efficacy of COV795 in Moderate to Severe Post-Operative Bunionectomy Pain With an Open-label Extension
Pain, Postoperative · Bunion
Primary: SPID48 (Summed Pain Intensity Difference) — 114.9; 66.9 scores on a scale
Phase 3 N=135 Residual Effect of Chlorhexidine-alcohol Compared to Triclosan-alcohol
Infectious Diseases
Primary: Evaluate the Residual Effect of Chlorhexidine 2% / Isopropyl Alcohol 70% Administered Topically — 24; 48; 24 (CFU/cm2) — p=<0.05
N/A N=119 Long-term Behavior Change - 1
Amphetamine-related Disorders
Primary: Methamphetamine Use During Intervention — 65.17; 60.35; 57.74; 42.81 percentage of negative urine samples — p=<0.01
Phase 2 N=122 Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus
Barrett Esophagus · Esophageal Cancer
Primary: Change in Mean Tissue Prostaglandin E2 (PGE2) Concentration as Determined From Barrett's Research Mucosal Biopsy Samples — -67.6; -123.9; -174.9 pg/mL — p=0.0955
Phase 2 N=170 Biobehavioral Interventions for HIV-negative, Stimulant Using Men Who Have Sex With Men
HIV Seroconversion · Stimulant Abuse
Primary: Time From Exposure to Truvada Initiation — 32.8; 33.0 hours
Phase 2 N=13 Effect of Galantamine on Smoking Abstinence
Nicotine Addiction
Primary: Number of Days of Abstinence During a 7-day Quit Attempt — 5 days
N/A N=66 Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma
Brain Tumor · Central Nervous System Tumor
Primary: Short Term Feasibility Success — 25 participants
Phase 2 N=46 Neural Substrates in Nicotine Withdrawal
Tobacco Use Disorder
Primary: Measure of Brain Activity: Blood Oxygen Level Dependent (BOLD) fMRI Signal Change During the "N-back" Working Memory Task (Brain Region: Right Dorsolateral Prefrontal…
N/A N=20 The Effect of a Non-hormonal Cox-2 Inhibitor (Celebrex) on Ovulation
Ovulation · Luteal Development
Primary: Number of Cycles With Ovulation Dysfunction When Taken After Ovulation: Extended Luteal Phase — 1; 6; 5 Participants
Phase 2 N=6 Immune Tolerance Study With Aldurazyme® (Laronidase)
Mucopolysaccharidosis I
Primary: Number of Participants Who Achieved Immune Tolerance Induction — 0; 1 participants